Genprex, Inc. Operating Cash Flow
Genprex, Inc. (GNPX) reported Operating Cash Flow of -$8.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- Genprex, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$5.14M.
- Genprex, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.14M.
- Genprex, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.10M.
- Genprex, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.19M.
- Genprex, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$15.31M.
- Genprex, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$17.92M.
- Genprex, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$24.74M.
- Genprex, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$17.62M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$8.28M 10-Q · filed 2026-08-14 | -$12.38M derived: sum of 3 quarters · filed 2026-08-14 | -$15.56M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$3.14M 10-Q · filed 2026-05-13 | -$7.24M derived: sum of 2 quarters · filed 2026-05-13 | -$10.42M derived: sum of 3 quarters · filed 2026-05-13 | -$14.29M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$7.29M derived: sum of 2 quarters · filed 2026-03-30 | -$11.15M derived: sum of 3 quarters · filed 2026-08-14 | -$15.31M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | -$3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$7.05M derived: sum of 2 quarters · filed 2026-08-14 | -$11.21M 10-Q · filed 2025-11-14 | -$15.08M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$3.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$8.03M 10-Q · filed 2026-08-14 | -$8.03M 10-Q · filed 2025-08-14 | -$11.90M derived: sum of 3 quarters · filed 2026-08-14 | -$14.08M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$4.16M 10-Q · filed 2026-05-13 | -$4.16M 10-Q · filed 2025-05-12 | -$8.03M derived: sum of 2 quarters · filed 2026-05-13 | -$10.22M derived: sum of 3 quarters · filed 2026-05-13 | -$16.79M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$6.06M derived: sum of 2 quarters · filed 2026-03-30 | -$12.62M derived: sum of 3 quarters · filed 2026-03-30 | -$17.92M 10-K · filed 2026-03-30 | -$17.15M 10-K · filed 2025-04-01 | |||
| 2024-09-30 | -$2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$8.76M derived: sum of 2 quarters · filed 2025-11-14 | -$14.05M 10-Q · filed 2025-11-14 | -$13.28M 10-Q · filed 2024-11-13 | -$19.02M derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | -$6.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$11.87M 10-Q · filed 2025-08-14 | -$11.09M 10-Q · filed 2024-08-09 | -$16.83M derived: sum of 3 quarters · filed 2025-08-14 | -$21.57M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$5.30M 10-Q · filed 2025-05-12 | -$10.26M derived: sum of 2 quarters · filed 2025-05-12 | -$15.00M derived: sum of 3 quarters · filed 2025-05-12 | -$23.10M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$4.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | -$9.70M derived: sum of 2 quarters · filed 2025-04-01 | -$17.81M derived: sum of 3 quarters · filed 2025-04-01 | -$24.74M 10-K · filed 2025-04-01 | ||||
| 2023-09-30 | -$4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$12.84M derived: sum of 2 quarters · filed 2024-11-13 | -$19.77M 10-Q · filed 2024-11-13 | -$19.77M 10-Q · filed 2023-11-14 | -$24.32M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | -$8.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$15.04M 10-Q · filed 2024-08-09 | -$19.59M derived: sum of 3 quarters · filed 2024-08-09 | -$24.11M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | -$6.93M 10-Q · filed 2024-05-15 | -$11.48M derived: sum of 2 quarters · filed 2024-05-15 | -$16.00M derived: sum of 3 quarters · filed 2024-05-15 | -$20.48M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$4.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$9.07M derived: sum of 2 quarters · filed 2024-04-01 | -$13.55M derived: sum of 3 quarters · filed 2024-04-01 | -$17.62M 10-K · filed 2024-04-01 | -$17.78M 10-K · filed 2023-03-31 | |||
| 2022-09-30 | -$4.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$9.00M derived: sum of 2 quarters · filed 2023-11-14 | -$13.07M 10-Q · filed 2023-11-14 | -$13.19M 10-Q · filed 2022-11-14 | -$16.29M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -$4.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | -$8.55M 10-Q · filed 2023-08-21 | -$8.62M 10-Q · filed 2022-08-12 | -$11.77M derived: sum of 3 quarters · filed 2023-08-21 | -$14.40M derived: sum of 4 quarters · filed 2023-08-21 | |||
| 2022-03-31 | -$4.07M 10-Q · filed 2023-05-22 | -$4.08M 10-Q · filed 2022-05-13 | -$7.29M derived: sum of 2 quarters · filed 2023-05-22 | -$9.92M derived: sum of 3 quarters · filed 2023-05-22 | -$12.89M derived: sum of 4 quarters · filed 2023-05-22 | |||
| 2021-12-31 | -$3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$5.85M derived: sum of 2 quarters · filed 2023-03-31 | -$8.82M derived: sum of 3 quarters · filed 2023-03-31 | -$14.28M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$5.60M derived: sum of 2 quarters · filed 2022-11-14 | -$11.07M 10-Q · filed 2022-11-14 | -$14.96M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$2.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$8.43M 10-Q · filed 2022-08-12 | -$12.32M derived: sum of 3 quarters · filed 2022-08-12 | -$14.34M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$5.47M 10-Q · filed 2022-05-13 | -$9.36M derived: sum of 2 quarters · filed 2022-05-13 | -$11.37M derived: sum of 3 quarters · filed 2022-05-13 | -$14.88M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$5.91M derived: sum of 2 quarters · filed 2022-03-30 | -$9.42M derived: sum of 3 quarters · filed 2022-03-30 | -$13.94M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | -$2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$5.53M derived: sum of 2 quarters · filed 2021-11-15 | -$10.04M 10-Q · filed 2021-11-15 | -$11.76M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$3.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$8.03M 10-Q · filed 2021-08-13 | -$9.75M derived: sum of 3 quarters · filed 2021-08-13 | -$11.74M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | -$4.52M 10-Q · filed 2021-05-17 | -$6.24M derived: sum of 2 quarters · filed 2021-05-17 | -$8.23M derived: sum of 3 quarters · filed 2021-05-17 | -$9.79M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | -$3.71M derived: sum of 2 quarters · filed 2021-03-26 | -$5.28M derived: sum of 3 quarters · filed 2021-03-26 | -$6.92M 10-K · filed 2021-03-26 | ||||
| 2019-09-30 | -$1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$3.56M derived: sum of 2 quarters · filed 2020-11-12 | -$5.20M 10-Q · filed 2020-11-12 | -$7.26M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | -$1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$3.21M 10-Q · filed 2020-08-11 | -$5.27M derived: sum of 3 quarters · filed 2020-08-11 | -$6.74M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | -$1.64M 10-Q · filed 2020-05-14 | -$3.70M derived: sum of 2 quarters · filed 2020-05-14 | -$5.17M derived: sum of 3 quarters · filed 2020-05-14 | -$8.28M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | -$2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$3.53M derived: sum of 2 quarters · filed 2020-03-30 | -$6.64M derived: sum of 3 quarters · filed 2020-03-30 | -$6.85M 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$4.58M derived: sum of 2 quarters · filed 2019-11-14 | -$4.78M 10-Q · filed 2019-11-14 | -$5.00M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$3.11M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2019-08-13 | -$3.31M 10-Q · filed 2019-08-13 | -$3.53M derived: sum of 3 quarters · filed 2019-08-13 | -$4.16M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | -$203.71K 10-Q/A · filed 2019-05-20 | -$415.28K derived: sum of 2 quarters · filed 2019-05-20 | -$1.05M derived: sum of 3 quarters · filed 2019-05-20 | -$1.73M derived: sum of 4 quarters · filed 2019-05-20 | ||||
| 2017-12-31 | -$211.57K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$850.50K derived: sum of 2 quarters · filed 2019-04-01 | -$1.52M derived: sum of 3 quarters · filed 2019-04-01 | -$2.17M 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | -$638.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$1.31M derived: sum of 2 quarters · filed 2018-11-14 | -$1.96M 10-Q · filed 2018-11-14 | -$1.96M 10-Q · filed 2017-12-05 | -$2.81M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | -$671.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$1.32M 10-Q · filed 2018-08-14 | -$2.17M derived: sum of 3 quarters · filed 2018-08-14 | |||||
| 2017-03-31 | -$649.31K 10-Q · filed 2018-05-15 | -$1.50M derived: sum of 2 quarters · filed 2018-05-15 | ||||||
| 2016-12-31 | -$848.64K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | -$1.25M 10-K · filed 2018-04-17 | ||||||
| 2016-09-30 | -$399.62K 10-Q · filed 2017-12-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |